Zejula (niraparib) is an oral medication used to treat certain types of ovarian cancer. It belongs to a class of drugs known as poly(ADP-ribose) polymerase (PARP) inhibitors.
UPC: | gsk-0000061 |
---|---|
رمز SKU للبائع: | gsk-0000061 |
حالة: | New |
التوفر: | في الأوراق المالية |
أقل كمية ممكن طلبها: | 1 |
التاريخ المدرج لأول مرة على Zandaux: | Sep 19, 2024 |
Zejula (niraparib) is an oral medication used to treat certain types of ovarian cancer. It belongs to a class of drugs known as poly(ADP-ribose) polymerase (PARP) inhibitors.
KEY FEATURES:
Used to treat ovarian cancer that is sensitive to PARP inhibitors.
Works by inhibiting PARP, an enzyme involved in DNA repair. This can lead to DNA damage in cancer cells, eventually eliminate them.
First-line maintenance therapy: After surgery and chemotherapy for advanced ovarian cancer.
Zejula should be prescribed by a healthcare professional experienced in treating ovarian cancer.
لم يتم تقديم تعليقات
عضو منذ: منذ 5 أشهر
نحن على بعد خطوة واحدة فقط! الرجاء تسجيل الدخول لبدء المحادثة. تسجيل الدخول